Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP was delisted on the 7th of March, 2019.
128 hedge funds and large institutions have $175M invested in Synergy Pharmaceuticals, Inc Common Stock in 2016 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 41 increasing their positions, 33 reducing their positions, and 23 closing their positions.
238% more call options, than puts
Call options by funds: $4.95M | Put options by funds: $1.46M
24% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 33
4% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 23
1% more funds holding
Funds holding: 127 → 128 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
51% less capital invested
Capital invested by funds: $360M → $175M (-$185M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$7.97M |
| 2 |
PC
Paulson & Co
New York
|
+$7.57M |
| 3 |
SG Americas Securities
New York
|
+$4.59M |
| 4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$3.42M |
| 5 |
FHAM
Folger Hill Asset Management
New York
|
+$2.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$7.03M |
| 2 |
TCP
Tourbillon Capital Partners
New York
|
-$5.56M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$4.05M |
| 4 |
MCM
Moore Capital Management
New York
|
-$3.77M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$3.67M |
SGYP Hedge Fund Activity: Q1 2016 in Review
128 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc Common Stock (SGYP) for Q1 2016, worth a combined $175M — down 51% from $360M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new SGYP positions and 23 closed out — a net gain of 1 holder — while 41 added to existing stakes and 33 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $7.97M. The largest seller was Citadel Advisors, cutting an estimated $7.03M.
- 128 institutional investors held Synergy Pharmaceuticals, Inc Common Stock (SGYP) as of Q1 2016, up from 127 in Q4 2015.
- Funds reported $175M of Synergy Pharmaceuticals, Inc Common Stock stock for Q1 2016, down 51% quarter-over-quarter.
- 24 funds opened new Synergy Pharmaceuticals, Inc Common Stock positions in Q1 2016 and 23 closed out, a net change of +1 holder.
- The largest Synergy Pharmaceuticals, Inc Common Stock buyer in Q1 2016 was Armistice Capital, an estimated $7.97M added.
- The largest Synergy Pharmaceuticals, Inc Common Stock seller in Q1 2016 was Citadel Advisors, an estimated $7.03M sold.
Based on aggregated 13F filings for Q1 2016.